ClinicalTrials.gg
Sign In

Brenner Tumor clinical trials

The registry lists 51 studies for Brenner Tumor across more than 10 countries. 0 are recruiting or about to start. 21 of them are mainly about Brenner Tumor (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-10.

Status

Completed
35
Terminated
8
Active, not recruiting
4
Status unknown
3
Withdrawn
1

Phase

Phase 1
19
Phase 2
15
Phase 3
13

Where

United States
46
Canada
6
Japan
4
Korea, Republic of
3
Norway
2
Singapore
1

Who runs them

Gynecologic Oncology Group (20) · National Cancer Institute (NCI) (14) · M.D. Anderson Cancer Center (2) · University of Washington (2) · GOG Foundation (2) · Fred Hutchinson Cancer Center (2) · Mayo Clinic (2) · Celgene (1)

What is being tested here

Drugs under test in Brenner Tumor studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Paclitaxel0818
Carboplatin0415
Bevacizumab047
Cisplatin035
Topotecan003
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter002
VTX-2337002
Docetaxel002
Erlotinib002
Paclitaxel poliglumex012

Drug classes tested here Antimitotic agents 19 · Tyrosine kinase inhibitors (TKIs) 4

Coming up

2phase 3 studies under way
0studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

Who these studies take

No Brenner Tumor study is recruiting now.

Across all 51 studies, recruiting or not: 6% stop at 75 or younger and 4% at 65; 25% take children; 88% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 → or search them.